Business / Finance

RSS

DePuy Synthes Spine signs representative agreement for marketing LifeNet Health's cellular allografts

DePuy Synthes Spine and DePuy Synthes Biomaterials, divisions of DePuy Orthopaedics, Inc., announced today they have entered into an exclusive worldwide representative agreement for the marketing and promotion of a new cellular allograft product developed by LifeNet Health, a world leader in allograft bio-implants and cellular therapies.

5 Feb 2014

OGT awarded NHS tender to supply oligo-based arrays for cytogenetics

Oxford Gene Technology, provider of innovative genetics research and biomarker solutions to advance molecular medicine, has been awarded a significant tender by the UK National Health Service for the supply of oligo-based arrays for cytogenetics.

From Oxford Gene Technology 4 Feb 2014

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces it has entered into a multi-step collaboration with XOMA Corporation, a leader in the discovery and development of therapeutic antibodies.

4 Feb 2014

Ablative Solutions completes $9.5M Series B Preferred Stock financing

Ablative Solutions, Inc., a privately-held clinical stage company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it has completed a Series B Preferred Stock financing, totaling approximately $9.5 million (including the conversion of the bridge financing completed in 2013), to fund its unique technology platform for renal denervation.

4 Feb 2014

Hy-Vee collaborates with UNMC and Ferris State to offer rapid-diagnostic influenza test

Getting tested and treated for the flu and strep throat became much easier today in Omaha. It's now as convenient as a trip to the grocery store.

4 Feb 2014

Thermo Fisher Scientific acquires Life Technologies

Thermo Fisher Scientific, the world leader in serving science, today announced that it has completed its acquisition of Life Technologies Corporation (NASDAQ: LIFE) for $76.13 ($76.1311786) in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows the receipt of all required regulatory approvals.

4 Feb 2014

LLHC Group signs definitive stock purchase agreement with BioScrip

LHC Group Inc., a national provider of home health, hospice and comprehensive post-acute healthcare services, announced today that it has signed a definitive stock purchase agreement with BioScrip, Inc. to purchase two of its operating subsidiaries, doing business as Deaconess HomeCare and Elk Valley Health Services, for $60 million.

4 Feb 2014

Ferrer executes two agreements to support clinical studies of Lorediplon in insomnia patients

Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has executed two agreements; with Ildong Pharmaceuticals Co Ltd, Korea and Ergomed Clinical Research Ltd, UK to support further clinical studies of Lorediplon in patients with insomnia.

3 Feb 2014

National Mentor Holdings enters into new senior secured credit facilities with Barclays Bank

National Mentor Holdings, Inc. today announced that it has entered into new senior secured credit facilities (the "New Senior Secured Credit Facilities") with Barclays Bank PLC, as administrative agent, and a syndicate of banks, to replace its existing senior secured credit facilities.

31 Jan 2014

Physio-Control enters into merger agreement with Sansio

Physio-Control, Inc., the world leader in emergency medical response technologies today announced it has entered into a merger agreement with Duluth, Minnesota-based Sansio - a leading provider of Software-as-a-Service (SaaS) solutions for the Emergency Medical Services (EMS) and home healthcare markets. The financial terms of the agreement were not disclosed.

31 Jan 2014

VIB and CD3 sign agreement with AstraZeneca for development of novel MALT1 inhibitors

VIB and CD3 (KU Leuven) today announced the signing of a license and collaboration agreement with AstraZeneca for the development of novel MALT1 inhibitors as therapeutics in inflammatory and oncological diseases.

31 Jan 2014

CICC signs agreement with BEUB to distribute nutriceutical products

On January 27, 2014, China Internet Cafe Holdings Group Inc. ("CICC" or the "Company") (OTCQB: CICC), a leading chain of Internet cafes in the People's Republic of China, announced that it signed a distribution agreement with Beijing Eastern Union Biopharmaceuticals, Ltd.

31 Jan 2014

Trevena prices initial public offering of common stock

Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.

31 Jan 2014

AbbVie's global sales reduce 1.8% to $5.111B in fourth quarter 2013

AbbVie today announced financial results for the fourth quarter and full year ended Dec. 31, 2013.

31 Jan 2014

YODA Project enters an agreement with Johnson & Johnson to gain access to clinical trial data assets

In a move that promotes open science, the Yale University Open Data Access (YODA) Project has entered an agreement with Johnson & Johnson that will enable scientists around the world to gain access to the company's clinical trial data assets.

30 Jan 2014

Zimmer Holdings fourth quarter net sales increase 5.1% to $1.24 billion

Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2013. The Company reported fourth quarter net sales of $1.24 billion, an increase of 5.1% reported and 6.6% constant currency over the fourth quarter of 2012.

30 Jan 2014

MEDNAX reports revenue growth of 20.4% to $567M in Q4 2013

MEDNAX, Inc., the national medical group specializing in neonatal, anesthesia, maternal-fetal, pediatric cardiology and other pediatric subspecialty physician services, today reported earnings of $0.78 per share for the three months ended December 31, 2013. MEDNAX's earnings per share data reflect the impact of a two-for-one stock split that was effective December 19, 2013.

30 Jan 2014

Nanomix announces closure of private financing for $12M

Nanomix Inc., (Nanomix), a leading nanotechnology company focused on development of next generation Point of Care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings, today announced that is has closed private financing for approximately $12 million.

30 Jan 2014

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2013. For the three months ended December 31, 2013, Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") reported net product sales of Soliris® (eculizumab) of $441.9 million, compared to $320.5 million for the same period in 2012.

30 Jan 2014

Thermo Fisher Scientific fourth quarter revenue increases 6% to $3.47 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2013.

30 Jan 2014

Business / Finance

DePuy Synthes Spine signs representative agreement for marketing LifeNet Health's cellular allografts

OGT awarded NHS tender to supply oligo-based arrays for cytogenetics

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

Ablative Solutions completes $9.5M Series B Preferred Stock financing

Hy-Vee collaborates with UNMC and Ferris State to offer rapid-diagnostic influenza test

Thermo Fisher Scientific acquires Life Technologies

LLHC Group signs definitive stock purchase agreement with BioScrip

Ferrer executes two agreements to support clinical studies of Lorediplon in insomnia patients

National Mentor Holdings enters into new senior secured credit facilities with Barclays Bank

Physio-Control enters into merger agreement with Sansio

VIB and CD3 sign agreement with AstraZeneca for development of novel MALT1 inhibitors

CICC signs agreement with BEUB to distribute nutriceutical products

Trevena prices initial public offering of common stock

AbbVie's global sales reduce 1.8% to $5.111B in fourth quarter 2013

YODA Project enters an agreement with Johnson & Johnson to gain access to clinical trial data assets

Zimmer Holdings fourth quarter net sales increase 5.1% to $1.24 billion

MEDNAX reports revenue growth of 20.4% to $567M in Q4 2013

Nanomix announces closure of private financing for $12M

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Thermo Fisher Scientific fourth quarter revenue increases 6% to $3.47 billion

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News